表紙：ジェネリック医薬品市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年、タイプ別、用途別、ドラッグデリバリー別、形態別、供給元別、流通チャネル別、地域別、競合別

市場調査レポート

商品コード

1266841

ジェネリック医薬品市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年、タイプ別、用途別、ドラッグデリバリー別、形態別、供給元別、流通チャネル別、地域別、競合別

Generic Drugs Market- Global Industry Size, Share, Trends, Opportunity and Forecast, 2018-2028F By Type, By Application, By Drug Delivery, By Form, By Source, By Distribution Channel, By Region and Competition

出版日: 2023年04月01日 | 発行: TechSci Research

| ページ情報: 英文 312 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 4,900 766,997円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷はできません。

PDF and Excel (Multi-User License)

USD 5,900 923,527円

レポートPDFおよびExcelデータシートを企業内でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。レポート内のデータを含むExcelが併せて納品されます。Excelはライセンスを付与された企業の社内でのご利用が可能です。PDF内コンテンツの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF and Excel (Custom Research License)

USD 8,900 1,393,117円

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.53円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

ジェネリック医薬品市場は、2022年に4,160億6,000万米ドルとなり、ジェネリック医薬品への需要の高まりにより、予測期間中にCAGR 6.51%でさらに成長すると予測されています。

ジェネリック医薬品市場は、慢性疾患の増加、特許切れ、低価格医薬品への需要の高まり、ジェネリック医薬品へのアクセスの容易さ、ジェネリック医薬品を認める政府への支援などの要因によって、今後数年間は成長を続けると予想されます。

慢性疾患の有病率の増加

遺伝的、環境的、行動的、生理的要因などの長期的な疾患による慢性疾患の有病率の増加が、予測期間中の市場成長を促進します。慢性疾患は、世界中のあらゆる年齢層に影響を与えています。また、COPDや喘息などの慢性呼吸器疾患、悪性腫瘍、糖尿病、心血管疾患などの非伝染性疾患は最も一般的な疾患であり、予測期間中にジェネリック医薬品の需要をさらに増加させることになります。同様に、急速な都市化、不健康なライフスタイルの世界化、高齢化の進展などの主要な要因が、予測期間中の市場の成長を促進すると予想されます。糖尿病、がん、心血管疾患などの慢性疾患の世界の有病率は急速に増加しています。その結果、手頃な価格で効果的な治療法に対する需要が高まり、ジェネリック医薬品市場の成長を牽引しています。つまり、時代とともに需要が高まるため、患者さんはジェネリック医薬品を好むのです。National Health Interview Surveyによると、米国の成人の51.8％が1つの慢性疾患を抱えており、約27％の人が複数の慢性疾患に悩まされています。WHOによると、世界中で年間3,800万人が慢性疾患の影響を受けていると言われています。WHOによると、慢性疾患による死亡者数は約4,100万人で、これは全世界の死亡者数の71％に相当します。このうち、心臓病による死亡者数は1,790万人、がんによる死亡者数は930万人、呼吸器疾患による死亡者は410万人、糖尿病による死亡者は150万人です。さらに、タバコの使用への曝露、アルコール消費の増加、運動不足など、他の要因も市場の成長に影響を及ぼしています。

慢性疾患は、ジェネリック医薬品市場の成長に大きな影響を与える可能性があります。慢性疾患は、継続的な診療を必要とし、しばしば薬の使用を必要とする、長く続く病状です。慢性疾患の例としては、糖尿病、高血圧症、関節炎、心臓病などが挙げられます。ジェネリック医薬品は、一般的にブランド品よりも安価であるため、多くの慢性疾患患者にとって魅力的な選択肢となっています。これは、ジェネリック医薬品メーカーが高価な研究開発や市場開拓に投資する必要がないためで、その分、低価格という形で消費者に還元されることになります。また、WHOの報告によると、慢性疾患は世界の死因のトップであり、2019年の全死亡者の71％を占めるとされています。しかし、世界保健機関（WHO）の「2021年タバコ喫煙の有病率の動向に関する世界報告」によると、世界の喫煙の有病率は2000年の27％から2020年には20％に減少しています。

ジェネリック医薬品の需要拡大

ブランド薬の特許切れは、世界のジェネリック医薬品市場の成長促進要因であり、イノベーションの機会を創出し、患者さんにとって薬がより身近なものになります。ブランド薬の特許が切れると、世界のジェネリック医薬品市場に大きな影響を与える可能性があります。特許が切れると、他のメーカーがその薬のジェネリックバージョンを製造・販売できるようになり、多くの場合、ブランド薬よりも低価格で販売できるようになります。このため、ジェネリック医薬品メーカーが市場に参入し、消費者により手頃な価格の選択肢を提供する機会が生まれます。その結果、ジェネリック医薬品の需要が増加し、ジェネリック医薬品市場の成長を促進することになります。例えば、セツキシマブは上皮成長因子受容体阻害剤で、転移性大腸がんや頭頸部がんの治療に使用されます。欧州ではブリストル・マイヤーズスクイブ社とイーライリリー社による特許に基づいて製造されており、2018年に特許が失効しています。そのため、多くの市場関係者がその後発品を製造する機会を提供することが期待されます。

競争の激化や価格の低下に加え、特許の失効はジェネリック医薬品市場におけるイノベーションをもたらす可能性があります。ジェネリック医薬品メーカーは、医薬品の新しい製剤やデリバリー方法を開発し、その有効性や患者の利便性を向上させる可能性があります。

しかし、すべての医薬品が特許満了時にジェネリック医薬品市場に大きな影響を与えるわけではないことに留意することが重要です。医薬品によっては、後発医薬品メーカーが製造しても採算が合わない場合や、先発医薬品が後発医薬品では容易に再現できない独自の特性を持っている場合があります。さらに、バイオシミラーの開発を促進するためのFDAによる支援策が、メーカーにその開発への注力を促しています。先発医薬品の特許が切れると、後発医薬品メーカーが市場に参入し、より低価格の医薬品を製造することができます。しかし、特許紛争があったり、先発医薬品メーカーが競合を遅らせる戦略をとったりすると、ジェネリック医薬品の入手が遅れる可能性があります。

低価格の医薬品への需要の高まり

低価格のジェネリック医薬品は、世界のジェネリック医薬品市場に大きな影響を与え、患者さんが医薬品をより安価に入手できるようにし、ヘルスケアシステムの財政負担を軽減し、医薬品業界のイノベーションを促進します。ジェネリック医薬品は通常、ブランド医薬品よりも安価であるため、患者さんにとってより手頃な選択肢となります。特に発展途上国では、安価な医薬品へのアクセスが限られているため、低価格のジェネリック医薬品を利用できることは、ヘルスケアシステムに大きな影響を与える可能性があります。このため、これらの地域ではジェネリック医薬品の需要が高まり、それが世界のジェネリック医薬品市場の成長に寄与しています。ジェネリック医薬品によるコスト削減は、ヘルスケアプロバイダー、保険会社、政府にもメリットがあります。ヘルスケアプロバイダーは、ジェネリック医薬品を使用することで、患者の治療費を削減することができ、ケアへのアクセスを改善し、患者やその家族の経済的負担を軽減することができます。

さらに、コストを下げるために、低価格のジェネリック医薬品は、製薬業界のイノベーションを促進することもできます。企業は、最も安価で効果的なジェネリック医薬品を製造するために競争するため、医薬品の製剤、デリバリー、効能を改善するための研究開発にさらに投資する可能性があります。2021年12月、米国FDAは、多発性硬化症の治療に使用される医薬品「Gilenya」の最初のジェネリック版を承認しました。

利用可能なカスタマイズ

与えられた市場データをもとに、TechSci Researchは企業の特定のニーズに応じてカスタマイズを提供します。本レポートでは、以下のカスタマイズが可能です：

会社情報

追加市場プレイヤー（最大5社）の詳細な分析およびプロファイリング

市場規模・予測
- 金額別
市場シェアと予測
- タイプ別（低分子ジェネリック医薬品とバイオシミラー医薬品）
- アプリケーション別（循環器疾患、糖尿病、神経、がん、抗炎症疾患、その他）
- ドラッグデリバリー（経口、局所、非経口、その他）別
- 形態別（錠剤、カプセル、注射、その他）
- 供給元別（インハウスと受託製造組織の違い）
- 流通チャネル別（病院薬局、小売薬局、オンライン薬局、その他）
- 企業別（2022年）
- 地域別
マーケットマップ
- タイプ別
- アプリケーション別
- ドラッグデリバリー別
- フォーム別
- ソース別
- 流通チャネル別
- 地域別

第6章北米ジェネリック医薬品市場の展望

市場規模・予測
- 金額別
市場シェアと予測
- タイプ別
- アプリケーション別
- ドラッグデリバリー別
- フォーム別
- ソース別
- 流通チャネル別
- 国別
北米の場合：国別分析
- 米国
- メキシコ
- カナダ

第7章欧州ジェネリック医薬品市場の展望

市場規模・予測
- 金額別
市場シェアと予測
- タイプ別
- アプリケーション別
- ドラッグデリバリー別
- フォーム別
- ソース別
- 流通チャネル別
- 国別
欧州：国別分析
- ドイツ
- 英国
- フランス
- イタリア
- スペイン

第8章アジア太平洋地域のジェネリック医薬品市場の展望

市場規模・予測
- 金額別
市場シェアと予測
- タイプ別
- アプリケーション別
- ドラッグデリバリー別
- フォーム別
- ソース別
- 流通チャネル別
- 国別
アジア太平洋地域の：国別分析
- 中国
- 日本
- 韓国
- インド
- オーストラリア

第9章南米ジェネリック医薬品市場の展望

市場規模・予測
- 金額別
市場シェアと予測
- タイプ別
- アプリケーション別
- ドラッグデリバリー別
- フォーム別
- ソース別
- 流通チャネル別
- 国別
南米：：国別分析
- ブラジル
- コロンビア
- アルゼンチン

第10章中東・アフリカのジェネリック医薬品市場展望

市場規模・予測
- 金額別
市場シェアと予測
- タイプ別
- アプリケーション別
- ドラッグデリバリー別
- フォーム別
- ソース別
- 流通チャネル別
- 国別
MEA：国別分析
- 南アフリカ共和国ジェネリック医薬品
- サウジアラビアジェネリック医薬品
- UAEジェネリック医薬品
- クウェートジェネリック医薬品

第11章市場力学

促進要因
課題すること

第12章市場の動向と開拓

最近の開発状況
M&A（合併・買収
製品発表会

第13章ジェネリック医薬品の世界市場：SWOT分析

第14章ポーターのファイブフォース分析

業界内の競合について
新規参入の可能性
サプライヤーの力
お客さまの力
代替品の脅威

第15章競合情勢

Teva Pharmaceutical Industries Ltd.
Sandoz International GmbH（Novartis AG）
Viatris Inc.
Sun Pharmaceutical Industries Ltd.
Fresenius Kabi AG
STADA Arzneimittel AG
Aurobindo Pharma Limited
Dr Reddy's Laboratories Ltd
Cipla Ltd
Novo Nordisk A/S
Abbott Laboratories Inc.
Endo Pharmaceuticals Inc.
Sanofi SA
Aspen Pharmacare Holdings Limited
Lupin Limited

第16章戦略的な提言

図表

List of Figures

Figure 1: Global Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 2: Global Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 3: Global Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 4: Global Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 5: Global Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 6: Global Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 7: Global Generic Drugs Market Share, By Distribution Channel , By Value, 2018-2028F
Figure 8: Global Generic Drugs Market Share, By Region, By Value, 2018-2028F
Figure 9: Global Generic Drugs Market Share, By Company, By Value, 2022
Figure 10: Global Generic Drugs Market Map, By Type, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 11: Global Generic Drugs Market Map, By Application, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 12: Global Generic Drugs Market Map, By Drug Delivery , Market Size (USD Billion) & Growth Rate (%), 2022
Figure 13: Global Generic Drugs Market Map, By Form, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 14: Global Generic Drugs Market Map, By Source, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 15: Global Generic Drugs Market Map, By Distribution Channel, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 16: Global Generic Drugs Market Map, By Region, Market Size (USD Billion) & Growth Rate (%), 2022
Figure 17: North America Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 18: North America Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 19: North America Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 20: North America Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 21: North America Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 22: North America Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 23: North America Generic Drugs Market Share, By Distribution Channel , By Value, 2018-2028F
Figure 24: North America Generic Drugs Market Share, By Country, By Value, 2018-2028F
Figure 25: United States Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 26: United States Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 27: United States Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 28: United States Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 29: United States Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 30: United States Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 31: United States Generic Drugs Market Share, By Distribution Channel , By Value, 2018-2028F
Figure 32: Canada Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 33: Canada Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 34: Canada Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 35: Canada Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 36: Canada Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 37: Canada Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 38: Canada Generic Drugs Market Share, By Distribution Channel , By Value, 2018-2028F
Figure 39: Mexico Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 40: Mexico Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 41: Mexico Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 42: Mexico Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 43: Mexico Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 44: Mexico Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 45: Mexico Generic Drugs Market Share, By Distribution Channel , By Value, 2018-2028F
Figure 46: Europe Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 47: Europe Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 48: Europe Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 49: Europe Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 50: Europe Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 51: Europe Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 52: Europe Generic Drugs Market Share, By Distribution Channel , By Value, 2018-2028F
Figure 53: Europe Generic Drugs Market Share, By Country, By Value, 2018-2028F
Figure 54: Germany Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 55: Germany Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 56: Germany Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 57: Germany Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 58: Germany Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 59: Germany Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 60: Germany Generic Drugs Market Share, By Distribution Channel , By Value, 2018-2028F
Figure 61: France Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 62: France Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 63: France Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 64: France Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 65: France Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 66: France Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 67: France Generic Drugs Market Share, By Distribution Channel , By Value, 2018-2028F
Figure 68: United Kingdom Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 69: United Kingdom Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 70: United Kingdom Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 71: United Kingdom Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 72: United Kingdom Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 73: United Kingdom Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 74: United Kingdom Generic Drugs Market Share, By Distribution Channel , By Value, 2018-2028F
Figure 75: Spain Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 76: Spain Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 77: Spain Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 78: Spain Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 79: Spain Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 80: Spain Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 81: Spain Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 82: Italy Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 83: Italy Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 84: Italy Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 85: Italy Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 86: Italy Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 87: Italy Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 88: Italy Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 89: Asia Pacific Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 90: Asia Pacific Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 91: Asia Pacific Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 92: Asia Pacific Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 93: Asia Pacific Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 94: Asia Pacific Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 95: Asia Pacific Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 96: Asia Pacific Generic Drugs Market Share, By Country, By Value, 2018-2028F
Figure 97: China Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 98: China Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 99: China Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 100: China Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 101: China Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 102: China Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 103: China Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 104: India Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 105: India Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 106: India Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 107: India Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 108: India Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 109: India Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 110: India Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 111: Japan Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 112: Japan Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 113: Japan Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 114: Japan Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 115: Japan Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 116: Japan Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 117: Japan Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 118: Australia Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 119: Australia Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 120: Australia Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 121: Australia Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 122: Australia Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 123: Australia Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 124: Australia Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 125: South Korea Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 126: South Korea Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 127: South Korea Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 128: South Korea Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 129: South Korea Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 130: South Korea Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 131: South Korea Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 132: South America Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 133: South America Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 134: South America Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 135: South America Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 136: South America Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 137: South America Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 138: South America Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 139: South America Generic Drugs Market Share, By Country, By Value, 2018-2028F
Figure 140: Brazil Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 141: Brazil Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 142: Brazil Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 143: Brazil Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 144: Brazil Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 145: Brazil Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 146: Brazil Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 147: Argentina Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 148: Argentina Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 149: Argentina Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 150: Argentina Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 151: Argentina Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 152: Argentina Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 153: Argentina Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 154: Colombia Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 155: Colombia Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 156: Colombia Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 157: Colombia Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 158: Colombia Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 159: Colombia Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 160: Colombia Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 161: Middle East & Africa Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 162: Middle East & Africa Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 163: Middle East & Africa Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 164: Middle East & Africa Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 165: Middle East & Africa Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 166: Middle East & Africa Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 167: Middle East & Africa Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 168: Middle East & Africa Generic Drugs Market Share, By Country, By Value, 2018-2028F
Figure 169: South Africa Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 170: South Africa Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 171: South Africa Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 172: South Africa Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 173: South Africa Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 174: South Africa Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 175: South Africa Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 176: Saudi Arabia Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 177: Saudi Arabia Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 178: Saudi Arabia Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 179: Saudi Arabia Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 180: Saudi Arabia Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 181: Saudi Arabia Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 182: Saudi Arabia Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 183: UAE Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 184: UAE Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 185: UAE Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 186: UAE Generic Drugs Market Share, By Drug Delivery, By Value, 2018-2028F
Figure 187: UAE Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 188: UAE Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 189: UAE Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F

Product Code: 7332

Generic Drugs Market was valued at USD 416.06 billion in 2022 and is further anticipated to grow at a CAGR of 6.51%, during the forecast period, owing to rising demand for generic drugs. The Generic Drugs market is expected to continue growing in the coming years, driven by factors such as the increasing prevalence of chronic diseases, expiration of patent drugs, growing demand for low-cost drugs, and easy accessibility and supportive governments for allowing generic drugs in the market.

The increasing aging population, along with the growing demand for low-cost generic drugs, will further drive the growth of the market during the forecast period. As consumers become more aware of the cost savings and efficacy of generic drugs, they are more likely to choose them over branded drugs which is a factor expected to drive the growth of the market during the forecast period. Generic drugs are used to treat a wide range of medical conditions, just like their branded counterparts. They contain the same active ingredients and are equivalent in strength, dosage, safety, and effectiveness.

Advancements in generic drugs have also contributed to the growth of the Generic Drugs market. Some generic drugs are now being developed as combination therapies, which combine two or more drugs into a single pill or other delivery systems. This can increase patient compliance and reduce the overall cost of treatment.

While the Generic Drugs market is growing rapidly, there are also several challenges that are impeding its growth. One of the biggest challenges the global generic drugs market is facing is ensuring the quality of generic drugs is the same as branded drugs. Others are Regulatory hurdles for approval of the generic drugs along with pricing pressures. Patent litigation is also a challenge that will hamper the growth of the global generic drugs market.

Growing Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases due to long-term illnesses such as genetic, environmental, behavioral, and physiological factors will drive the growth of the market during the forecast period. Chronic diseases impact all ages across the globe. Also, non-communicable diseases such as chronic respiratory diseases such as COPD, asthma, malignancies and, diabetes, cardiovascular diseases are the most common diseases, which will further increase the demand for generic drugs in the forecast period. Similarly, some major factors like rapid urbanization, globalization of leading unhealthy lifestyle, and the growing aging population is expected to drive the growth of the market during the forecast period. The global prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is increasing rapidly. As a result, there is a growing demand for affordable and effective treatments, which has driven the growth of the generic drugs market. So, patients prefer generic drugs as demand grows with time. According to the National Health Interview Survey, 51.8% of U.S adults have one chronic disease, and approx. 27% of people are suffering from several chronic diseases. Per year, 38 million people are affected because of chronic diseases across the globe, according to WHO. According to WHO, chronic diseases affect almost 41 million people, which is equivalent to 71% of all deaths globally; among these, 17.9 million deaths are caused for heart disease, 9.3 million deaths are caused due to cancer, and 4.1 million deaths due to respiratory diseases, 1.5 million deaths due to diabetes per year. Additionally, other factors are also influencing the growth of the market, such as exposure to the use of tobacco, increasing consumption of alcohol, and physical inactivity.

Chronic diseases can have a significant impact on the growth of the generic drugs market. Chronic diseases are long-lasting medical conditions that require ongoing medical attention and often require the use of medication. Examples of chronic diseases include diabetes, hypertension, arthritis, and heart disease. Generic drugs are an attractive option for many patients with chronic diseases because they are typically less expensive than their branded counterparts. This is because generic drug manufacturers do not have to invest in expensive research and development or marketing campaigns, which can be passed on to consumers in the form of lower prices. The WHO also reports that chronic diseases are the leading cause of death worldwide, accounting for 71% of all deaths in 2019. However, according to the World Health Organization's 2021 Global Report on Trends in Prevalence of Tobacco Smoking, the global prevalence of smoking has decreased from 27% in 2000 to 20% in 2020.

Growing Demand for Generic Drugs

The expiration of patents for branded drugs is a major driver of growth in the global generic drugs market, creating opportunities for innovation and making medications more accessible to patients. The expiration of patents for branded drugs can have a significant impact on the global generic drugs market. When a patent expires, it allows other manufacturers to produce and sell generic versions of the drug, often at a lower cost than the branded drug. This creates an opportunity for generic drug manufacturers to enter the market and offer more affordable options to consumers. As a result, the demand for generic drugs increases, driving growth in the generic drugs market. For example, Cetuximab is an epidermal growth factor receptor inhibitor that is used for the treatment of metastatic colorectal cancer and head and neck cancer. It is manufactured under the patent by Bristol-Myers Squibb and Eli Lily Company in Europe, and it expired in 2018. It is thus expected to provide an opportunity for a large number of market players to manufacture its generic version.

In addition to increasing competition and lowering prices, the expiration of patents can also lead to innovation in the generic drugs market. Generic drug manufacturers may develop new formulations or delivery methods for the drug, improving its efficacy and convenience for patients.

However, it is important to note that not all drugs have a significant impact on the generic drugs market when their patents expire. Some drugs may not be profitable for generic manufacturers to produce, or the original drug may have unique properties that cannot be easily replicated by a generic version. Additionally, a supportive initiative by the FDA for promoting the development of biosimilars is encouraging manufacturers to focus on its development. As patents on brand-name drugs expire, generic drug manufacturers can enter the market and produce lower-cost versions of the drug. However, the availability of generic drugs can still be delayed if there are patent disputes or if the brand-name manufacturer implements strategies to delay competition.

Growing Demand for Low-Cost Drugs

Low-cost generic drugs have a significant impact on the global generic drugs market, making medications more affordable and accessible to patients, reducing the financial burden on healthcare systems, and driving innovation in the pharmaceutical industry. Generic drugs are typically less expensive than their branded counterparts, which makes them a more affordable option for patients. The availability of low-cost generic drugs can have a major impact on healthcare systems, particularly in developing countries, where access to affordable medications can be limited. This has led to increased demand for generic drugs in these regions, which has, in turn, contributed to the growth of the global generic drugs market. The cost savings associated with generic drugs also benefit healthcare providers, insurance companies, and governments. By using generic drugs, healthcare providers can reduce the cost of treatment for their patients, which can improve access to care and reduce the financial burden on patients and their families.

Additionally, to lower costs, low-cost generic drugs can also drive innovation in the pharmaceutical industry. As companies compete to produce the most affordable and effective generic versions of a drug, they may further invest in research and development to improve the formulation, delivery, and efficacy of the drug. In December 2021, the US FDA approved the first generic version of the drug Gilenya, used to treat multiple sclerosis.

Recent Development

In November 2021, the Indian government announced a new policy aimed at reducing the cost of generic drugs and promoting their use in the country.
In September 2021, a study published in the Journal of the American Medical Association found that the use of generic drugs can lead to significant cost savings for patients with diabetes in the United States.
In August 2021, the US FDA approved the first generic version of the drug Advair Diskus, used to treat asthma and chronic obstructive pulmonary disease (COPD).
In July 2021, the World Health Organization (WHO) launched a new initiative aimed at increasing access to generic drugs and reducing the cost of medications worldwide.

Market Segmentation

Global generic drugs market is segmented based on type, application, drug delivery, form, source, distribution channel, and region. Based on type, the market is divided into Small Molecule Generics vs. Biosimilars. Based on application, the market is further segmented into Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others. Based on drug delivery, the market is differentiated into Oral, Topical, Parenteral, and Others. Based on form, the market is segmented into tablets, Capsules, Injections, and Others. Based on the source, the market is divided into In House vs. Contract Manufacturing Organizations. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others.

Market Players

Teva Pharmaceutical Industries Ltd, Sandoz International GmbH (Novartis AG), Viatris Inc., Sun Pharmaceutical Industries Ltd., Fresenius Kabi AG, STADA Arzneimittel AG, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd, Cipla Ltd, Novo Nordisk A/S, Abbott Laboratories Inc., Endo Pharmaceuticals Inc., Sanofi SA, Aspen Pharmacare Holdings Limited, Lupin Limited, among others, are some of the key players operating in the global Generic Drugs Market.

Report Scope:

In this report, Global Generic Drugs Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Generic Drugs Market, By Type:

Small Molecule Generics
Biosimilars

Generic Drugs Market, By Application:

Cardiovascular Diseases
Diabetes
Neurology
Oncology
Anti-Inflammatory Diseases
Others

Generic Drugs Market, By Drug Delivery:

Oral
Topical
Parenteral
Others

Generic Drugs Market, By Form:

Tablet
Capsule
Injection
Others

Generic Drugs Market, By Source:

In House
Contract Manufacturing Organizations

Generic Drugs Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Generic Drugs Market, By Region:

North America
- United States
- Canada
- Mexico

Europe
- Germany
- France
- United Kingdom
- Spain
- Italy

Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea

South America
- Brazil
- Colombia
- Argentina

Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global Generic Drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

ジェネリック医薬品市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年、タイプ別、用途別、ドラッグデリバリー別、形態別、供給元別、流通チャネル別、地域別、競合別

Generic Drugs Market- Global Industry Size, Share, Trends, Opportunity and Forecast, 2018-2028F By Type, By Application, By Drug Delivery, By Form, By Source, By Distribution Channel, By Region and Competition

慢性疾患の有病率の増加

ジェネリック医薬品の需要拡大

低価格の医薬品への需要の高まり

最近の開発状況

利用可能なカスタマイズ

会社情報

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 VOC (顧客の声)

第5章 ジェネリック医薬品の世界市場展望

第6章 北米ジェネリック医薬品市場の展望

第7章 欧州ジェネリック医薬品市場の展望

第8章 アジア太平洋地域のジェネリック医薬品市場の展望

第9章 南米ジェネリック医薬品市場の展望

第10章 中東・アフリカのジェネリック医薬品市場展望

第11章 市場力学

第12章 市場の動向と開拓

第13章 ジェネリック医薬品の世界市場：SWOT分析

第14章 ポーターのファイブフォース分析

第15章 競合情勢

第16章 戦略的な提言

List of Figures

Growing Prevalence of Chronic Diseases

Growing Demand for Generic Drugs

Growing Demand for Low-Cost Drugs

Recent Development

Market Segmentation

Market Players

Report Scope:

Generic Drugs Market, By Type:

Generic Drugs Market, By Application:

Generic Drugs Market, By Drug Delivery:

Generic Drugs Market, By Form:

Generic Drugs Market, By Source:

Generic Drugs Market, By Distribution Channel:

Generic Drugs Market, By Region:

Competitive Landscape

Available Customizations:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Generic Drugs Market Outlook

6. North America Generic Drugs Market Outlook

7. Europe Generic Drugs Market Outlook

8. Asia-Pacific Generic Drugs Market Outlook

9. South America Generic Drugs Market Outlook

10. Middle East and Africa Generic Drugs Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Generic Drugs Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

第1章概要

第2章調査手法

第3章エグゼクティブサマリー

第5章ジェネリック医薬品の世界市場展望

第6章北米ジェネリック医薬品市場の展望

第7章欧州ジェネリック医薬品市場の展望

第8章アジア太平洋地域のジェネリック医薬品市場の展望

第9章南米ジェネリック医薬品市場の展望

第10章中東・アフリカのジェネリック医薬品市場展望

第11章市場力学

第12章市場の動向と開拓

第13章ジェネリック医薬品の世界市場：SWOT分析

第14章ポーターのファイブフォース分析

第15章競合情勢

第16章戦略的な提言